The aim of this study is to assess the relationship between adenomyosis/myoma and lower urinary tract symptoms, sexual function and gastrointestinal symptoms.
All outpatient patients were found to have \>3 cm uterine myoma or adenomyosis were invited to participate in this study. The size and location of uterine myoma or adenomyosis and the uterus should be assessed by ultrasonography. Besides, all enrolled female patients will be asked to complete overactive bladder symptom score, female bladder function (UDI-6 \& IIQ-7), female sexual function index, and bowel incontinence assessment questionnaires. In addition, patients who underwent surgeries for myoma or adenomyosis will be requested to complete the above questionnaires at 3 months after surgery. Women with intact uterus should be assessed again by ultrasonography. At least 30 women with age and body mass index matched and without uterine myoma or adenomyosis will be invited to participate in this study as the control group.
Study Type
OBSERVATIONAL
Enrollment
150
Far-Eastern Memorial Hospital
Banqiao District, New Taipei, Taiwan
RECRUITINGThe corrleation coefficient between the size of myoma and Overactive Bladder Symptoms Scores
The Spearman's correlation between the size of uterine myoma and the score of Overactive Bladder Symptoms Scores
Time frame: 12 weeks
The corrleation coefficient between the size of myoma and the presence of constipation/diarrhea
The Spearman's correlation between the size of uterine myoma and the presence of constipation/diarrhea
Time frame: 12 weeks
Comparison of Overactive Bladder Symptoms Scores between the adenomyosis group and the control group
Comparison of Overactive Bladder Symptoms Scores between the adenomyosis group and the control group by Wilcoxon rank-sum test
Time frame: 12 weeks
Comparisons of the constipation/diarrhea rates between the adenomyosis group and the control group
Comparisons of the constipation/diarrhea rates between the adenomyosis group and the control group by Chi-square test or Fisher's exact test
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.